Latest review: 9 May 2026

Phase-one launch copy separates UK availability from overseas approval and keeps provider comparison focused on readiness, not live oral GLP-1 obesity tablet pricing.

Update triggers

We review this site when regulators publish approval changes, manufacturers announce UK launch timing, major UK providers publish live access pages, confirmed prices appear, or safety warnings change.